InnoCan Pharma Corporation (CSE: INNO)
Canada
· Delayed Price · Currency is CAD 0.210
+0.015 (7.69%)
Dec 30, 2024, 4:00 PM EST
InnoCan Pharma Revenue
InnoCan Pharma had revenue of $8.62M USD in the quarter ending September 30, 2024, with 111.22% growth. This brings the company's revenue in the last twelve months to $28.93M, up 192.24% year-over-year. In the year 2023, InnoCan Pharma had annual revenue of $13.66M with 433.69% growth.
Revenue (ttm)
$28.93M
Revenue Growth
+192.24%
P/S Ratio
1.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
60.26M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| WELL Health Technologies | 957.69M |
| Curaleaf Holdings | 1.83B |
| dentalcorp Holdings | 1.51B |
| Trulieve Cannabis | 1.58B |
| Sienna Senior Living | 867.55M |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |